...
首页> 外文期刊>Journal of drug delivery science and technology >Multiunit floating drug delivery system of acyclovir: Development, characterization and in vitro-in vivo evaluation of spray-dried hollow microspheres
【24h】

Multiunit floating drug delivery system of acyclovir: Development, characterization and in vitro-in vivo evaluation of spray-dried hollow microspheres

机译:阿昔洛韦的多单元漂浮药物递送系统:喷雾干燥空心微球的开发,表征和体内体外评估

获取原文
获取原文并翻译 | 示例
           

摘要

Acyclovir, anti-herpes virus drug, was loaded in hollow microspheres to improve bioavailability and patient compliance by prolonging the residence time in the gastrointestinal tract. The hollow microspheres of acyclovir were prepared by spray-drying method using ethyl cellulose as a drug-controlled release polymer. We found that the selected process parameters of spray-drying method like inlet temperature, outlet temperature, spray flow rate and vacuum pressure can give rise to hollow microspheres with good yields of production, high drug content and buoyancy, narrow size distribution and good encapsulation efficiency. The size of the microspheres prepared from different ratios of acyclovir and ethyl cellulose was 1.1-2.7 μm. When the drug:polymer ratio was increased, the size and percent drug content increased. The hollow microspheres having higher polymer concentrations were less buoyant than those with lower polymer concentrations. The formulation HSF1 showed the highest buoyancy of 94.18 ± 4.4%. Dissolution profiles indicate that when drug:polymer ratio increased from 1:2 to 1:6, a decrease in release rate was observed. The highest correlation coefficient was obtained in first-order release model as compared to zero-order followed by Higuchi model. From the Higuchi plot it was found that drug release from the microspheres was diffusion type. The 'n' values from Korsmeyer-peppas model indicated that all three formulations follow Fickian diffusion controlled release. The AUC values for oral administration of selected formulation and conventional tablet (Zovirax) clearly indicated two- to three-fold improvement in the bioavailability of acyclovir from prepared formulation when compared to conventional commercial tablet.
机译:阿昔洛韦(抗疱疹病毒药物)被装在空心微球中,以通过延长在胃肠道中的停留时间来提高生物利用度和患者依从性。使用乙基纤维素作为药物控释聚合物,通过喷雾干燥法制备了阿昔洛韦的空心微球。我们发现,选择喷雾干燥方法的工艺参数,如入口温度,出口温度,喷雾流速和真空压力,可以产生中空微球,产量高,药物含量和浮力高,尺寸分布窄,包封效率高。 。由无环鸟苷和乙基纤维素的不同比例制备的微球的尺寸为1.1-2.7μm。当药物:聚合物比率增加时,尺寸和药物含量百分比增加。具有较高聚合物浓度的中空微球比具有较低聚合物浓度的中空微球浮力小。配方HSF1显示最高浮力94.18±4.4%。溶出曲线表明,当药物与聚合物的比例从1:2增加到1:6时,观察到释放速率降低。与零阶随后的Higuchi模型相比,在一阶发行模型中获得了最高的相关系数。从Higuchi图可以发现,微球中的药物释放是扩散型的。 Korsmeyer-peppas模型的n值表明,所有三种配方均遵循Fickian扩散控制释放。与常规的市售片剂相比,口服施用选定制剂和常规片剂(Zovirax)的AUC值清楚地表明,从所制备的制剂中无环鸟苷的生物利用度提高了2-3倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号